References
- Schaaf JM, Mol BWJ, Abu-Hanna A, Ravelli ACJ. Trends in preterm birth: singleton and multiple pregnancies in the Netherlands, 2000–2007. BJOG. 2011; 118:1196–204.
- WHO: Recommended definitions, terminology and format for statistical tables related to the perinatal period and use of a new certificate for cause of perinatal deaths. Modifications recommended by FIGO as amended October 14, 1976. Acta Obstet Gynecol Scand. 1977; 56:247–53.
- Saigal S, Doyle LW. An overview of mortality and sequelae of preterm birth from infancy to adulthood. Lancet. 2008; 371(9608):261–9.
- Chawanpaiboon S, Kanokpongsakdi S. Preterm birth at Siriraj Hospital: a 9-year period review (2002–2010). Siriraj Med J. 2011; 63:143–6.
- Martin JA, Hamilton BE, Osterman MJK, Driscoll AK, Mathews TJ; Division of Vital Statistics. Births: final data for 2015. Natl Vital Stat Rep. 2017; 66:1–69. Hyattsville, MD: National Center for Health Statistics; 2017.
- Deshpande SN, van Asselt AD, Tomini F, Armstrong N, Allen A, Noake C, et al. Rapid fetal fibronectin testing to predict preterm birth in women with symptoms of premature labour: a systematic review and cost analysis. Health Technol Assess. 2013; 17:1–138.
- Hass DM. Preterm birth. BMJ Clin Evid. 2011; 2011:1404. PMCID: PMC3217816
- Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2006; (3): CD004454. doi: 10.1002/14651858.CD004454.pub2
- Antenatal Corticosteroids Revisited: Repeat Courses—National Institutes of Health Consensus Development Conference Statement, August 17–18, 2000 National Institutes of Health Consensus Development Panel. Obstet Gynecol. 2001; 98:144–50.
- van Baaren G-J, Vis JY, Grobman WA, Bossuyt PM, Opmeer BC, Mol BW. Cost-effectiveness analysis of cervical length measurement and fibronectin testing in women with threatened preterm labor. Am J Obstet Gynecol. 2013; 209:436.e1–8. doi: 10.1016/j.ajog.2013.06.029
- Weichert A, Weichert TM, Bergmann RL, Henrich W, Kalache KD, Richter R, et al. Factors for preterm births in Germany – an analysis of representative German data (KiGGS). Geburtshilfe Frauenheilkd. 2015; 75:819–26.
- Nicholson WK, Frick KD, Powe NR. Economic burden of hospitalizations for preterm labor in the United States. Obstet Gynecol. 2000; 96:95–101.
- McPheeters ML, Miller WC, Hartmann KE, Savitz DA, Kaufman JS, Garrett JM, Thorp JM. The epidemiology of threatened preterm labor: a prospective cohort study. Am J Obstet Gynecol. 2005; 192:1325–9; discussion 9–30.
- American College of Obstetricians and Gynecologists; Committee on Practice Bulletins—Obstetrics. ACOG practice bulletin No. 171: Management of preterm labor. Obstet Gynecol. 2016; 128:e155–64. doi: 10.1097/AOG.0000000000001711
- Di Renzo GC, Roura LC, Facchinetti F, Antsaklis A, Breborowicz G, Gratacos E, et al. Guidelines for the management of spontaneous preterm labor: identification of spontaneous preterm labor, diagnosis of preterm premature rupture of membranes, and preventive tools for preterm birth. J Matern Fetal Neonatal Med. 2011; 24:659–67.
- Oskovi Kaplan ZA, Ozgu-Erdinc AS. Prediction of preterm birth: maternal characteristics, ultrasound markers, and biomarkers: an updated overview. J Pregnancy. 2018; 2018:8367571. doi: 10.1155/2018/8367571
- Buyukbayrak EE, Turan C, Unal O, Dansuk R, Cengizoğlu B. Diagnostic power of the vaginal washing-fluid prolactin assay as an alternative method for the diagnosis of premature rupture of membranes. J Matern Fetal Neonatal Med. 2004; 15:120–5.
- Lee SM, Romero R, Park JW, Kim SM, Park CW, Korzeniewski SJ, et al. The clinical significance of a positive Amnisure test in women with preterm labor and intact membranes. J Matern Fetal Neonatal Med. 2012; 25:1690–8.
- Ting H-S, Chin P-S, Yeo GSH, Kwek K. Comparison of bedside test kits for prediction of preterm delivery: phosphorylated insulin-like growth factor binding protein-1 (pIGFBP-1) test and fetal fibronectin test. Ann Acad Med Singapore. 2007; 36:399–402.
- Bohn, H., Kraus, W. Isolierung und charakterisierung eines neuen plazentaspezifischen proteins (PP12) [Isolation and characterization of a new placenta specific protein (PP12)]. Arch Gynecol. 1980; 229:279–91. [in German, English abstract]
- Wing DA, Haeri S, Silber AC, Roth CK, Weiner CP, Echebiri NC, et al. Placental alpha microglobulin-1 compared with fetal fibronectin to predict preterm delivery in symptomatic women. Obstet Gynecol. 2017; 130:1183–91.
- Lee SM, Lee J, Seong HS, Lee SE, Park JS, Romero R, Yoon BH. The clinical significance of a positive Amnisure test in women with term labor with intact membranes. J Matern Fetal Neonatal Med. 2009; 22:305–10.
- Kobayashi K, Miwa H, Yasui M. Inflammatory mediators weaken the amniotic membrane barrier through disruption of tight junctions. J Physiol. 2010; 588(Pt 24):4859–69.
- Melchor JC, Navas H, Marcos M, Iza A, De Diego M, Rando D, et al. Predictive performance of PAMG-1 vs fFN test for risk of spontaneous preterm birth in symptomatic women attending an emergency obstetric unit: retrospective cohort study. Ultrasound Obstet Gynecol. 2018; 51:644–9.
- Pirjani R, Moini A, Almasi-Hashiani A, Farid Mojtahedi M, Vesali S, Hosseini L, Sepidarkish M. Placental alpha microglobulin-1 (PartoSure) test for the prediction of preterm birth: a systematic review and meta-analysis. J Matern Fetal Neonatal Med. 2019:1–13. doi: 10.1080/14767058.2019.1685962
- Sanin-Blair J, Palacio M, Delgado J, Figueras F, Coll O, Cabero L, et al. Impact of ultrasound cervical length assessment on duration of hospital stay in the clinical management of threatened preterm labor. Ultrasound Obstet Gynecol. 2004; 24:756–60.
- Iams JD. Prediction and early detection of preterm labor. Obstet Gynecol. 2003; 101:402–12.
- van Baaren GJ, Vis JY, Wilms FF, Oudijk MA, Kwee A, Porath MM, et al. Predictive value of cervical length measurement and fibronectin testing in threatened preterm labor. Obstet Gynecol. 2014; 123:1185–92.
- Revah A, Hannah ME, Sue-A-Quan AK. Fetal fibronectin as a predictor of preterm birth: an overview. Am J Perinatol. 1998; 15: 613–21.
- Çekmez Y, Kýran G, Haberal ET, Dizdar M. Use of cervicovaginal PAMG-1 protein as a predictor of delivery within seven days in pregnancies at risk of premature birth. BMC Pregnancy Childbirth. 2017; 17:246. doi: 10.1186/s12884-017-1427-0
- Nikolova T, Bayev O, Nikolova N, Di Renzo GC. Comparison of a novel test for placental alpha microglobulin-1 with fetal fibronectin and cervical length measurement for the prediction of imminent spontaneous preterm delivery in patients with threatened preterm labor. J Perinat Med. 2015; 43:395–402.
- Bolotskikh V, Borisova V. Combined value of placental alpha microglobulin-1 detection and cervical length via transvaginal ultrasound in the diagnosis of preterm labor in symptomatic patients. J Obstet Gynaecol Res. 2017; 43:1263–9.
- Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig L, et al.; STARD Group. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. Clin Chem. 2015; 61:1446–52.